Drug Topics

FEBRUARY 13, 2025

A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.

FDA 359

FDA 359

STAT

FEBRUARY 13, 2025

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I apologize for this depressing, cynical newsletter. I still hope you read it.  Why it’s so bleak out there My recent conversations with folks in the biotech investing world can only be described as bleak.

FDA 134

FDA 134

Drug Topics

FEBRUARY 13, 2025

What are some key strategies for keeping your pharmacy thriving in 2025?

247

247

STAT

FEBRUARY 13, 2025

It’s no secret that life expectancy in the United States is among the lowest in the developed world and has been since long before the Covid-19 pandemic.  The United States  ranked  29 th  in life expectancy at birth among peer nations in the Organization for Economic Cooperation and Development despite spending almost twice as much on clinical care per person as the average OECD nation.

Insurance 107

Insurance Hospitals 107

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

FEBRUARY 13, 2025

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

247

247

PharmaVoice

FEBRUARY 13, 2025

The two companies will let their long-running contract expire this year, and drugmakers will need to decide which is the best platform for them in a changing marketplace.

194

194

Pharmacy Times

FEBRUARY 13, 2025

Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.

65

65

Drug Topics

FEBRUARY 13, 2025

Pharmacy industry experts gathered for a webinar detailing the upcoming trends expected to take shape in 2025.

247

247

Pharmacy Times

FEBRUARY 13, 2025

The agency will now review the novel PCSK9 inhibitor for possible approval in patients with or at high risk of atherosclerotic cardiovascular disease.

FDA 145

FDA 145

Drug Topics

FEBRUARY 13, 2025

A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

FEBRUARY 13, 2025

New analysis by VTT Technical Research Centre of Finland has highlighted the EUs completely underestimated costs of the newly enforced Urban Wastewater Treatment Directive. Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Fierce Healthcare

FEBRUARY 13, 2025

Immediately following Senate confirmation, Robert F. Kennedy Jr. has been named chair of the Make America Healthy Again Commission, which will be focused on chronic disease and transparency in medical research.

140

140

Pharmacy Times

FEBRUARY 13, 2025

The expanding role of real-world evidence in regulatory and health technology assessment (HTA) decision-making highlights its growing acceptance for supplementing clinical trial data, addressing evidence gaps, and informing treatment value, despite challenges in data quality, accessibility, and regulatory compliance.

131

131

PhRMA

FEBRUARY 13, 2025

PhRMA recently submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) proposed rule which would extend coverage of anti-obesity medicines (AOMs) in Medicare Part D and state Medicaid plans. Currently, AOMs are excluded from Medicare Part D coverage and optional in state Medicaid programs, when used specifically for the treatment of obesity, because they’re labeled as “agents used for weight loss.

Labelling 130

Labelling 130

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

FEBRUARY 13, 2025

Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.

131

131

Fierce Healthcare

FEBRUARY 13, 2025

Nationwide median operating margin for rural hospitals sits at 1%, though that metric is negative in 16 states and worsened in Medicaid non-expansion states.

Hospitals 113

Hospitals 113

Pharmacy Times

FEBRUARY 13, 2025

Andrew Lin, PharmD, BCOP, discusses his pharmacist-led study examining the association between early tacrolimus levels and outcomes post-allogeneic hematopoietic cell transplantation.

131

131

Fierce Healthcare

FEBRUARY 13, 2025

Hims & Hers hit the bullseye with its Super Bowl adit sparked a lot of attention from consumers for its brand and weight loss products. But the controversial ad also caught the attention of the pharma industry and lawmakers, who lashed the company for "deceptive" advertising.

108

108

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

FEBRUARY 13, 2025

Currently, the Cadherin-6 targeting antibody-drug conjugate is undergoing evaluation in a phase 1a/1b clinical trial.

FDA 123

FDA 123

pharmaphorum

FEBRUARY 13, 2025

The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.

102

102

Pharmacy Times

FEBRUARY 13, 2025

The combination greatly improved progression-free survival and overall survival.

Chemotherapy 118

Chemotherapy 118

pharmaphorum

FEBRUARY 13, 2025

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.

78

78

Pharmacy Times

FEBRUARY 13, 2025

Diabetes management through insulin could play a significant role in preventing antibiotic resistance.

115

115

pharmaphorum

FEBRUARY 13, 2025

Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.

76

76

Pharmacy Times

FEBRUARY 13, 2025

Talazoparib in combination with enzalutamide yielded significant improvements in radiographic progression-free survival and overall survival.

109

109

pharmaphorum

FEBRUARY 13, 2025

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by E coli looks all but defunct after they abandon a phase 3 trial

Vaccines 74

Vaccines 74

Pharmacy Times

FEBRUARY 13, 2025

Building on a previously granted orphan drug designation, the latest FDA action for amezalpat puts the drug in a position for regulatory approval.

FDA 94

FDA 94

Pharmaceutical Technology

FEBRUARY 13, 2025

AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based immunotherapies.

64

64

Pharmacy Times

FEBRUARY 13, 2025

This surgery can be significant in reducing the long-term risk of adverse outcomes and decompensation in cirrhosis related to metabolic dysfunction-associated steatohepatitis (MASH).

85

85

Fierce Healthcare

FEBRUARY 13, 2025

As the use of GLP-1 weight loss medications continues to grow, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these drugs, a new survey found.

63

63

Pharmacy Times

FEBRUARY 13, 2025

Panelists discuss how health care professionals collaborate through interdisciplinary teams, integrated care coordination, and lifecycle-specific approaches to provide comprehensive womens health care, addressing gaps by implementing patient-centered, culturally sensitive models that prioritize holistic well-being across different life stages.

65

65

STAT

FEBRUARY 13, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! A friend and former journalism school classmate wrote a beautiful essay in the New York Times yesterday about grieving with Paddington (the bear and film franchise). I can’t recommend it enough.

63

63

The Checkup by Singlecare

FEBRUARY 13, 2025

Ibuprofen ( Advil and Motrin ) is a nonsteroidal anti-inflammatory drug ( NSAID ) approved by the U.S. Food and Drug Administration (FDA) for mild to moderate pain relief and reduced fever for health conditions like rheumatoid arthritis , muscle aches , toothaches, and backaches. According to James Lyons, MD, a board-certified physician in psychiatry, family medicine, hospitalist care, and emergency medicine, and the medical consultant for Synergy Houses, while the medication is not addictive, s

FDA 59

FDA 59